Obesity News

In patients with obesity, gastric bypass surgery plus a very low-energy diet reduced major atherogenic blood lipids to a greater degree than a very low-energy diet alone at 6 weeks, according to the results of the COCKTAIL trial.

Teva Pharmaceuticals launched the first generic GLP-1 receptor agonist, liraglutide 1.8 mg, for patients aged 10 years or older with type 2 diabetes.

This year’s American Society for Nutrition Scientific Sessions and Annual Meeting will take place in person in Chicago from June 29 to July 2.

A 5:2 intermittent fasting diet combined with meal replacement resulted in greater weight loss and better glycemic control compared with antidiabetic medications in patients with early-stage type 2 diabetes, data from the EARLY study showed.

Results of a phase 2 trial showed that 89% of children and adults with hypothalamic obesity had a 5% or greater reduction in BMI after receiving setmelanotide over 16 weeks.

In patients with obesity-driven heart failure with preserved ejection fraction, semaglutide 2.4 mg was associated with more improvement in NYHA functional class compared with placebo, according to new data from the STEP-HFpEF trials.

ORLANDO — Adults with obesity who reduce their body weight lower their odds for developing an obesity-related cancer, according to data presented at the American Diabetes Association Scientific Sessions.

In patients with obesity and obstructive sleep apnea, those who had weight-loss surgery had approximately 40% reduced risk for major adverse CV events and death compared with those who did not, according to the results of the MOSAIC study.

In a final recommendation statement, the U.S. Preventive Services Task Force said that health care professionals should refer or provide youth aged 6 years and older with high BMI to intensive, comprehensive behavioral interventions.

The relationship between obesity and disordered eating behaviors represents a complex combination of psychological, physiological and environmental influences.